EOLS – evolus, inc. (US:NASDAQ)

DELAYED
$ usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day EOLS SPY QQQ SPX
Date
Time
Symbol
Company Name
Action
%Chg
3/3/2026
04:05 pm
eols
evolus, inc.
BEAT
35.4%
11/5/2025
04:05 pm
eols
evolus, inc.
BEAT
5.4%
8/5/2025
04:05 pm
eols
evolus, inc.
MISS
-28.5%
5/7/2025
04:05 pm
eols
evolus, inc.
MISS
-14.2%
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions?
The answers are right here.
Stock Stats
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Top News Gainers
6/4 Form 4/A Evolus, Inc. For: Jun 03 Filed by: Alphaeon Corp 16.7%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
Top News Decliners
5/15 ALPHAEON Corporation sells 4 million shares in Evolus Inc. -11.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%

Don’t Miss Out On The Next BIG Stock Move

Thanks for submitting the form.
EOLS – evolus, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EOLS
SPY
QQQ
SPX
EOLS – evolus, inc. (US:NASDAQ)
DELAYED
$ usd
1D
5D
1M
3M
YTD
1Y
3Y
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
EOLS SPY QQQ SPX
Stock Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
Stock Stats
Order Stats
Sub-Penny
Odd Lot
Avg. bid-ask spread
Avg. bid / ask size
Shares at ask / bid
Off exchange
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
News
3/5
04:22 pm
eols
Medium
AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting [Yahoo! Finance]
3/4
04:56 pm
eols
Low
Evolus, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
3/4
08:00 am
eols
High
Evolus (EOLS) had its "buy" rating reaffirmed by BTIG Research. They now have a $13.00 price target on the stock.
3/4
02:48 am
eols
High
Evolus, Inc. (EOLS) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/4
02:47 am
eols
High
Evolus outlines 2026 revenue guidance of $327M–$337M while expanding international presence and product portfolio [Seeking Alpha]
3/4
12:15 am
eols
High
Evolus Inc (EOLS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges [Yahoo! Finance]
3/3
07:17 pm
eols
High
Evolus Q4 Earnings Call Highlights [Yahoo! Finance]
3/3
06:25 pm
eols
High
Evolus (EOLS) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/3
04:20 pm
eols
High
Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026 [Yahoo! Finance]
3/3/2026
04:05 pm
eols
35.4%
BEAT
11/5/2025
04:05 pm
eols
5.4%
BEAT
8/5/2025
04:05 pm
eols
-28.5%
MISS
5/7/2025
04:05 pm
eols
-14.2%
MISS
Earnings are essential to understanding the financial health of a company listed on any Stock Exchange. But what are Earnings, how are they calculated, when are they announced, and how are they used to make sound investment decisions? The answers are right here.
3/4
08:00 am
Reiterates
Buy
Buy
BTIG Research
High
15.2%
3/4
04:38 am
Reiterates
Buy
Buy
BTIG
High
18.4%
1/22
04:48 am
Maintains
Buy
Buy
BTIG
Low
2.8%
1/13
12:59 pm
Maintains
Buy
Buy
Stifel
Medium
3.2%
1/9
12:46 pm
Reiterates
Buy
Buy
HC Wainwright
Low
2.7%
12/24
08:02 am
Reiterates
Hold
Hold
Needham & Company LLC
Medium
-3.3%
12/24
06:03 am
Reiterates
Hold
Hold
Needham
0.0%
12/24
06:03 am
Reiterates
Hold
Hold
Needham
0.0%
3/3
05:08 pm
eols
High
Form S-8 Evolus, Inc.
3/3
05:02 pm
eols
High
Form 10-K Evolus, Inc. For: Dec 31
3/3
04:30 pm
eols
High
Form 8-K Evolus, Inc. For: Mar 03
2/19
08:58 pm
eols
Low
Form 4 Evolus, Inc. For: Feb 17 Filed by: Parschauer Karah Herdman
2/19
08:58 pm
eols
Low
Form 4 Evolus, Inc. For: Feb 17 Filed by: Mitchell Tatjana
2/19
08:58 pm
eols
Low
Form 4 Evolus, Inc. For: Feb 17 Filed by: Stewart Brady
2/19
08:58 pm
eols
Low
Form 4 Evolus, Inc. For: Feb 17 Filed by: White Albert G III
2/19
08:57 pm
eols
Low
Form 4 Evolus, Inc. For: Feb 17 Filed by: Malik Vikram
2/19
08:57 pm
eols
Low
Form 4 Evolus, Inc. For: Feb 17 Filed by: MOATAZEDI DAVID
Show more
Top News Gainers
6/4 Form 4/A Evolus, Inc. For: Jun 03 Filed by: Alphaeon Corp 16.7%
11/7 Evolus Announces Pricing of Public Offering of Common Stock 14.3%
7/17 Form 4 Evolus, Inc. For: Jul 15 Filed by: Parschauer Karah Herdman 11.6%
5/17 Form 424B4 Evolus, Inc. 8.0%
8/8 Juvly Aesthetics Continues Its Leadership Expansion with Appointment of a Chief People Officer 6.7%
2/25 Form 10-K Evolus, Inc. For: Dec 31 6.0%
5/21 ALPHAEON Corporation to Pay Off $88 million of Outstanding Third-Party Debt 5.4%
7/16 Form 8-K Evolus, Inc. For: Jul 15 4.8%
10/15 Evolus Inc (NASDAQ: EOLS) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 4.4%
5/31 Form 4 Evolus, Inc. For: May 31 Filed by: SILVERNAIL LAUREN P 4.2%
Top News Decliners
5/15 ALPHAEON Corporation sells 4 million shares in Evolus Inc. -11.2%
8/13 Evolus Inc (NASDAQ: EOLS) had its "outperform" rating re-affirmed by analysts at JMP Securities. They now have a $30.00 price target on the stock. -11.0%
3/17 Form DEF 14A Evolus, Inc. For: May 01 -10.7%
2/25 Q4/2019 12/31/2019 EPS -0.470 ZacksConsensus -0.850 ActVsEst 0.380 - Beat -8.6%
3/27 Evolus Inc (NASDAQ: EOLS) had its price target lowered by analysts at HC Wainwright from $31.00 to $16.00. They now have a "buy" rating on the stock. -8.0%
3/4 Evolus Provides Update on International Trade Commission (ITC) Case -7.7%
1/9 Form 8-K Evolus, Inc. For: Jan 09 -7.0%
1/10 Form 8-K Evolus, Inc. For: Jan 10 -6.8%
3/3 Evolus to Participate in Barclays 2020 Global Healthcare Conference -6.3%
8/12 Q2/2019 6/30/2019 EPS -1.370 ZacksConsensus -0.960 ActVsEst (0.410) - Miss -6.2%